Commerce Bank boosted its holdings in shares of Agilent Technologies Inc (NYSE:A) by 0.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 103,758 shares of the medical research company’s stock after buying an additional 413 shares during the quarter. Commerce Bank’s holdings in Agilent Technologies were worth $7,431,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in A. NuWave Investment Management LLC raised its position in shares of Agilent Technologies by 1,116.1% in the first quarter. NuWave Investment Management LLC now owns 377 shares of the medical research company’s stock valued at $27,000 after purchasing an additional 346 shares during the period. First Bank & Trust acquired a new stake in Agilent Technologies during the fourth quarter worth approximately $29,000. Citizens Financial Group Inc RI boosted its holdings in shares of Agilent Technologies by 260.0% during the fourth quarter. Citizens Financial Group Inc RI now owns 360 shares of the medical research company’s stock worth $31,000 after acquiring an additional 260 shares during the period. FinTrust Capital Advisors LLC boosted its holdings in shares of Agilent Technologies by 450.7% during the fourth quarter. FinTrust Capital Advisors LLC now owns 380 shares of the medical research company’s stock worth $32,000 after acquiring an additional 311 shares during the period. Finally, Sowa Financial Group Inc. grew its position in shares of Agilent Technologies by 1,425.0% in the first quarter. Sowa Financial Group Inc. now owns 488 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 456 shares during the last quarter.
Several research firms recently issued reports on A. Needham & Company LLC downgraded Agilent Technologies from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a research note on Monday, February 24th. Cfra reduced their target price on shares of Agilent Technologies from $60.00 to $57.00 and set a “hold” rating for the company in a research report on Friday, February 21st. Royal Bank of Canada started coverage on shares of Agilent Technologies in a research report on Tuesday, April 28th. They set a “sector perform” rating on the stock. Wells Fargo & Co lifted their price objective on shares of Agilent Technologies from $82.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, SunTrust Banks decreased their target price on shares of Agilent Technologies from $90.00 to $75.00 and set a “hold” rating on the stock in a research report on Thursday, April 16th. Eleven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $83.25.
Shares of NYSE:A traded up $5.52 during midday trading on Friday, reaching $86.27. The company’s stock had a trading volume of 117,711 shares, compared to its average volume of 2,093,521. The firm has a market capitalization of $25.30 billion, a price-to-earnings ratio of 35.67 and a beta of 1.10. The firm has a 50 day moving average price of $77.14 and a two-hundred day moving average price of $79.93. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.27 and a current ratio of 1.64. Agilent Technologies Inc has a fifty-two week low of $61.13 and a fifty-two week high of $90.64.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Thursday, May 21st. The medical research company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.61 by $0.10. Agilent Technologies had a net margin of 14.59% and a return on equity of 20.49%. The company had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter in the previous year, the company earned $0.71 earnings per share. Agilent Technologies’s revenue for the quarter was up .2% on a year-over-year basis. As a group, research analysts anticipate that Agilent Technologies Inc will post 2.95 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 29th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.83%. Agilent Technologies’s payout ratio is currently 23.15%.
In other Agilent Technologies news, CEO Michael R. Mcmullen sold 18,018 shares of Agilent Technologies stock in a transaction on Friday, May 8th. The stock was sold at an average price of $80.00, for a total transaction of $1,441,440.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Michael R. Mcmullen sold 13,603 shares of the company’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $78.72, for a total transaction of $1,070,828.16. Following the completion of the sale, the chief executive officer now directly owns 529,245 shares of the company’s stock, valued at approximately $41,662,166.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 43,929 shares of company stock valued at $3,476,727.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
See Also: What is operating income?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.